SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the June 2024 quarter is pegged at Rs. 3897.48 millions, about 12.43% up against Rs. 3466.67 millions recorded during the year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 214.84 millions grew from Rs.-157.03 millionsThe company reported a good operating profit of 489.73 millions compared to 141.35 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3897.48 3466.67 12.43 3897.48 3466.67 12.43 14421.68 10724.32 34.48
Other Income 87.74 58.26 50.60 87.74 58.26 50.60 303.86 418.48 -27.39
PBIDT 489.73 141.35 246.47 489.73 141.35 246.47 813.05 -510.65 -259.22
Interest 13.82 24.75 -44.16 13.82 24.75 -44.16 104.20 93.80 11.09
PBDT 475.91 116.60 308.16 475.91 116.60 308.16 132.77 -1731.09 -107.67
Depreciation 261.07 273.63 -4.59 261.07 273.63 -4.59 1054.58 1059.79 -0.49
PBT 214.84 -157.03 -236.81 214.84 -157.03 -236.81 -921.81 -2790.88 -66.97
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 206.12 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 206.12 0.00
PAT 214.84 -157.03 -236.81 214.84 -157.03 -236.81 -921.81 -2997.00 -69.24
Equity 140.81 140.81 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 12.57 4.08 208.17 12.57 4.08 208.17 5.64 -4.76 -218.40

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×